HIVClinicalForum
Meeting category
Date(s)
27 Oct 2020
CME credits
4
Organizer

European HIV Clinical Forum 2020

Related Enduring Materials

Enduring Materials
Program

Tuesday, 27 October 2020

- 13:00
13:00 CET
Welcome, Introductions, and Goals: Guidance on Using Online Format and Online Needs Assessment
Anne-Geneviève  Marcelin
Anne-Genevieve Marcelin, PharmD, PhD
Hôpital Pitié-Salpétrière, France
Session 1: State-of-the-Art Lectures: Update on Clinical Trials and Their Significance for Patient Management -
Chair
Anne-Geneviève  Marcelin
Anne-Genevieve Marcelin, PharmD, PhD
Hôpital Pitié-Salpétrière, France
13:10 CET
Clinical Update: Oral Therapies for Drug Naïve and Suppressed Patients
Gary Rubin, MD, MCFP, AAHIVS
University of Toronto, Canada
13:25 CET
Video
Charles Flexner, MD
Johns Hopkins University School of Medicine, United States
13:40 CET
Clinical Update: Highly Treatment Experienced Patients
Michael Kozal, MD
Stanford University School of Medicine, United States
13:55 CET
Discussion
Session 2: Reduced Drug Regimens: Scientific Considerations -
Chair
Jonathan Schapiro
Jonathan Schapiro, MD
National Hemophilia Center, Sheba Medical Center, Israel
14:30 CET
Video
Diane Descamps, MD, PHD
Hopital Bichat-claude Bernard, France
14:45 CET
Virology and Immunology: Implications for Reservoirs/Cure
Mathias Lichterfeld, MD, PhD
Partners AIDS Research Center, United States
15:00 CET
Pharmacology: Implications for Poor Adherence and Sanctuary Sites
Charles Flexner, MD
Johns Hopkins University School of Medicine, United States
15:15 CET
Round Table Discussion
Session 3: Clinical Implementation of Long-Acting Therapies -
Chair
Charles Flexner
Charles Flexner, MD
Johns Hopkins University School of Medicine, United States
15:50 CET
Virological and Pharmacological Monitoring: How and How Often?
Andrea Calcagno, MD, DTM&H
University of Torino, Italy
16:05 CET
Management of Drug-Drug Interactions and Poor Adherence
Kimberly Scarsi, PharmD, MS, FCCP
University of Nebraska Medical Center (UNMC), United States
16:20 CET
Financial Considerations in Oral Versus Parenteral HIV Therapy
Andrew Hill
Andrew Hill, MD
Liverpool University, UK
16:35 CET
Discussion
Session 4: Roundtable: Social / Logistical Barriers to Implementation of PrEP in Europe: What’s the Same, What’s Different? -
Moderator
Anton Pozniak
Anton Pozniak, MD, FRCP
Chelsea and Westminster Hospital, United Kingdom
17:10 CET
Southern Europe
Pep Coll, MD
AIDS Research Institute-IrsiCaixa, Spain
17:20 CET
Western Europe
Christoph Boesecke, MD
Universitätsklinikum Bonn, Germany
17:30 CET
Eastern Europe
David Jilich, MD, Ph.D
Hospital Na Bulovce, Czech Republic
17:40 CET
Roundtable Discussion
18:00 CET
Summary and Closure of the Program
Anton Pozniak
Anton Pozniak, MD, FRCP
Chelsea and Westminster Hospital, United Kingdom
Overview

The European HIV Clinical Forum 2020 provided an independent scientific program involving the world’s leading experts and is specifically designed for European HIV healthcare professionals and focuses on optimizing treatment for their patients. 

This program featured challenging plenary lectures followed by ample time for Q&A and debate, stimulating interaction, and the sharing of knowledge within the HIV-treating community in Europe. The program included virtual networking opportunities for community building; thus, providing delegates with the unique opportunity to meet their colleagues in a focused and scientific setting.

The HIV Clinical Forum is a series of interactive programs that provide an independent scientific program on emerging topics in HIV, involving experts where HIV clinicians and allied healthcare professionals receive updates on the latest developments related to HIV management, where they can share their clinical experience, and present results from their ongoing and completed cohorts/ research programs.

Furthermore, the HIV Clinical Forum provides an educational setting where healthcare professionals can acquire specific skills that will enhance their capabilities to interpret research results and even develop new research projects.

Program Directors
Local Chair

General Information 

COVID-19 Update
The European HIV Clinical Forum 2020: Optimizing Treatment took place on 27 October 2020 as a fully virtual meeting. Participants attended plenary sessions and round-table discussions on the day of the meeting.

We are available to answer any questions or concerns that you may have about your participation at the European HIV Clinical Forum 2020: Optimizing Treatment. For more information, please contact Mrs. Dagmar Jónasdóttir at Dagmar@amededu.com.

To stay updated on developments in relation to this forum meeting, make sure that you are signed up for our newsletter.
Meeting Objectives
With the HIV Clinical Forum program we aim to:

- Build a community of healthcare professionals devoted to providing optimal clinical care for their patients

- Create a platform for interactive information exchange on novel treatment options

- Translate the latest research achievements into clinical guidance for the optimal management of individuals living with HIV
Learning Objectives
After participating in the HIV Clinical Forum, participants will be able to:

- Understand the clinical data supporting novel treatment strategies

- Describe the pros and cons of novel treatment strategies

- Understand how to integrate novel treatment strategies into routine patient care

- Be knowledgeable of the clinical data supporting long-acting injectable regimens

- Identify patients who might best benefit from long acting injectable regimens

- Know how best to integrate injectable drugs in to routine clinical care

- Improve their skills in defining and identifying complex HIV patients

- Stay informed on new drug options for complex patients

- Understand how best to use new treatment options in complex HIV patients
Practical Information 
Certificate of Attendance
A certificate of attendance was sent by e-mail to participants shortly after the forum meeting.
Disclaimer
This forum meeting is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of meeting, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from the meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending this forum meeting.
Language
The official language of this meeting was English. Translation was not provided.
Liability and Insurance
By registering for this forum meeting, participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, as well as audio and video recordings, are not permitted at the official forum meeting sessions. Only the official medical writer, appointed by the organizer, may make recordings. All presentations will be posted on the forum website as soon as possible after the meeting is finished, provided that the speaker has given their permission to do so.
Committees
Program Chairs
Local Chair

The Program Chairs are a group of carefully selected experts and inspirational leaders in their respective fields. They meet frequently to discuss the scientific program of the forum meeting, identify interesting topics and candidate speakers, and review all submitted abstracts.

Support

The European HIV Clinical Forum 2020 is supported by an independent educational grant from ViiV Healthcare.

ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.

Endorsers
Language